Spasmolytic polypeptide-expressing metaplasia, Wfdc2 knockout/tamoxifen-induced, in mouse (C57BL/6)

Cat.No.:	AB68685
Species:	Mus musculus (mouse)
Animal Type:	mouse
Strain:	C57BL/6
Target/Condition/Toxicity:	Condition
Model Use:	Spasmolytic polypeptide-expressing metaplasia
Characteristic(Details):	Chemical agent-induced Knockout
Disease Area:	Spasmolytic polypeptide-expressing metaplasia

For research use only. Not intended for any clinical use.

Protheragen provides comprehensive solutions for animal behavior testing for preclinical research.

Models

Services

USA

Denmark